Sandu Pharmaceuticals is currently trading at Rs. 58.65, up by 1.10 points or 1.91% from its previous closing of Rs. 57.55 on the BSE.
The scrip opened at Rs. 61.90 and has touched a high and low of Rs. 61.90 and Rs. 56.50 respectively. So far 5193 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 75.90 on 03-Jan-2022 and a 52 week low of Rs. 27.45 on 22-Mar-2021.
Last one week high and low of the scrip stood at Rs. 65.50 and Rs. 55.00 respectively. The current market cap of the company is Rs. 47.41 crore.
The promoters holding in the company stood at 48.02%, while Institutions and Non-Institutions held 0.01% and 51.97% respectively.
Sandu Pharmaceuticals’ board has approved incorporation of a wholly owned subsidiary of the company namely ‘Sandu Phytoceuticals’. The proposed wholly owned subsidiary company to be incorporated in India shall carry out business in the field of Pharmaceuticals/ Phytoceuticals Products. The incorporation of the wholly owned subsidiary will leverage the growth opportunities and will help the company in becoming more broad based and focused. The Board of Director of the company in its meeting held on February 14, 2022 has approved the same.
Sandu Pharmaceuticals, popularly called by people Sandu Ayurveda, is one of the renewed brands when it's come to Ayurvedic health care Products or Medicines.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1858.70 |
Dr. Reddys Lab | 1258.55 |
Cipla | 1559.20 |
Lupin | 2198.25 |
Zydus Lifesciences | 1004.00 |
View more.. |